COVID-19

Patients, n:49

MIS-C Patients, n:68

p-value

Odds ratio (95% Confidence interval)

Gender

 Male (n, %)

22 (44.9)

36 (52.9)

0.391

Age, Months, (median ± SD)

146.2 ± 50

104.1 ± 58.7

< 0.001

Weight-SDS (median, IQR)

0.49 (2.3)

-0.06 (1.35)

0.087

Height-SDS (median, IQR)

0.21 (1.18)

0.39 (2.39)

0.527

Obesity (n, %)

7 (14.3)

5 (7.5)

0.233

BMI-SDS (median, IQR kg/m²)

0.3 (1.95)

-0.43 (2.14)

0.204

WBC (mean ± SD,/mm³)

6992 ± 1989

11228 ± 6403

< 0.001

Hb (mean ± SD, gr/dL)

13.1 ± 1.6

11.1 ± 1.4

< 0.001

Platelet (mean ± SD,/mm³)

295449 ± 66065

20638 ± 11359

< 0.001

CRP (mean ± SD, mg/L)

2.5 ± 5.3

172 ± 76

< 0.001

ESR (mean ± SD, mm/h)

7.4 ± 7.6

60.3 ± 33.4

< 0.001

Ferritin (median, IQR, µg/L)

40.5 (52)

390 (409)

< 0.001

Albumin (mean ± SD, mg/dL)

4.5 ± 0.45

3.5 ± 0.7

< 0.001

NT-pro BNP (median ± IQR, ng/L)

37.5 (59.5)

2582 (7717)

< 0.001

Troponin T (mean ± SD, ng/L)

13 ± 0

34.9 ± 58.9

0.003

Cholesterol (mean ± SD, mg/dL)

146 ± 29

128 ± 37

0.02

Hypercholesterolemia (n, %)

2 (4.1)

2 (3)

1

Triglyceride (mean ± SD, mg/dL)

86 ± 52

181 ± 89

< 0.001

Hypertriglyceridemia (n, %)

6 (12.2)

10 (15.2)

0.656

HDL- C (median, IQR, mg/dL)

56 ± 18

25 ± 24

< 0.001

Low HDL-C (n, %)

7 (14.3)

57 (86.4)

< 0.001

38 (13.098-110.244)

LDL- C (mean ± SD, mg/dL)

77.8 ± 22.4

66.8 ± 34

0.043

High LDL-C (n, %)

1 (2)

5 (7.8)

0.231

Insulin (mean ± SD, mU/L)

11.7 ± 8.7

22.3 ± 19

< 0.001

Glucose (mean ± SD, mg/dL)

86.3 ± 6.7

93.6 ± 24.8

0.024

HOMA-IR (mean ± SD)

2.5 ± 1.8

5.5 ± 5.2

< 0.001

Insulin Resistance (n, %)

11 (22.4)

38 (60.3)

< 0.001

5.251 (2.268-12.159)

TyG index (mean ± SD)

4.4 ± 0.25

4.8 ± 0.28

< 0.001

High Tyg index (n, %)

12 (24.5)

57 (87.7)

< 0.001

21.969 (8.199-58.867)